Cover Image
市場調查報告書

Huons Co., Ltd.:產品平台分析

Huons Co., Ltd. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 340848
出版日期 內容資訊 英文 29 Pages
訂單完成後即時交付
價格
Back to Top
Huons Co., Ltd.:產品平台分析 Huons Co., Ltd. - Product Pipeline Review - 2015
出版日期: 2015年08月26日 內容資訊: 英文 29 Pages
簡介

本報告提供Huons Co., Ltd.的醫藥品開發平台現狀及各開發階段比較分析與藥物簡介,提供您標的,給藥途徑,分子類型,各作用機制的藥物評估等資訊。

Huons Co., Ltd.的基本資料

  • 概要
  • 主要資訊
  • 企業資料

Huons Co., Ltd.:R&D概要

  • 主要的治療範圍

Huons Co., Ltd.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品
  • 合作夥伴產品
    • 合作夥伴產品/聯合治療模式

Huons Co., Ltd.:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

Huons Co., Ltd.:開發階段不明的開發中產品

  • 開發階段不明的產品/聯合治療模式

Huons Co., Ltd.:藥物簡介

  • HU-002
  • HU-010
  • HU-005
  • cyclosporine
  • HU-001
  • HU-003
  • HU-012

Huons Co., Ltd.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Huons Co., Ltd.:企業發表

Huons Co., Ltd.:總公司和子公司的所在地

附錄

目錄
Product Code: GMDHC07441CDB

Summary

Global Markets Direct's, 'Huons Co., Ltd. - Product Pipeline Review - 2015', provides an overview of the Huons Co., Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Huons Co., Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Huons Co., Ltd. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Huons Co., Ltd.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Huons Co., Ltd.'s pipeline products

Reasons to buy

  • Evaluate Huons Co., Ltd.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Huons Co., Ltd. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Huons Co., Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Huons Co., Ltd. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Huons Co., Ltd.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Huons Co., Ltd. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Huons Co., Ltd. Snapshot
    • Huons Co., Ltd. Overview
    • Key Information
    • Key Facts
  • Huons Co., Ltd. - Research and Development Overview
    • Key Therapeutic Areas
  • Huons Co., Ltd. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
  • Huons Co., Ltd. - Pipeline Products Glance
    • Huons Co., Ltd. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
    • Huons Co., Ltd. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
    • Huons Co., Ltd. - Unknown Stage Pipeline Products
      • Unknown Products/Combination Treatment Modalities
  • Huons Co., Ltd. - Drug Profiles
    • HU-002
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • HU-010
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • HU-005
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • cyclosporine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • HU-001
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • HU-003
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • HU-012
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Huons Co., Ltd. - Pipeline Analysis
  • Huons Co., Ltd. - Pipeline Products by Target
  • Huons Co., Ltd. - Pipeline Products by Route of Administration
  • Huons Co., Ltd. - Pipeline Products by Molecule Type
  • Huons Co., Ltd. - Pipeline Products by Mechanism of Action
  • Huons Co., Ltd. - Company Statement
  • Huons Co., Ltd. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Huons Co., Ltd., Key Information
  • Huons Co., Ltd., Key Facts
  • Huons Co., Ltd. - Pipeline by Indication, 2015
  • Huons Co., Ltd. - Pipeline by Stage of Development, 2015
  • Huons Co., Ltd. - Monotherapy Products in Pipeline, 2015
  • Huons Co., Ltd. - Partnered Products in Pipeline, 2015
  • Huons Co., Ltd. - Partnered Products/ Combination Treatment Modalities, 2015
  • Huons Co., Ltd. - Phase II, 2015
  • Huons Co., Ltd. - Preclinical, 2015
  • Huons Co., Ltd. - Unknown, 2015
  • Huons Co., Ltd. - Pipeline by Target, 2015
  • Huons Co., Ltd. - Pipeline by Route of Administration, 2015
  • Huons Co., Ltd. - Pipeline by Molecule Type, 2015
  • Huons Co., Ltd. - Pipeline Products by Mechanism of Action, 2015
  • Huons Co., Ltd., Other Locations

List of Figures

  • Huons Co., Ltd. - Pipeline by Top 10 Indication, 2015
  • Huons Co., Ltd. - Pipeline by Stage of Development, 2015
  • Huons Co., Ltd. - Monotherapy Products in Pipeline, 2015
  • Huons Co., Ltd. - Partnered Products in Pipeline, 2015
  • Huons Co., Ltd. - Pipeline by Top 10 Target, 2015
  • Huons Co., Ltd. - Pipeline by Top 10 Route of Administration, 2015
  • Huons Co., Ltd. - Pipeline by Top 10 Molecule Type, 2015
  • Huons Co., Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top